Literature DB >> 7512236

The actions of phenylglycine derived metabotropic glutamate receptor antagonists on multiple (1S,3R)-ACPD responses in the rat nucleus of the tractus solitarius.

S R Glaum1, D C Sunter, P M Udvarhelyi, J C Watkins, R J Miller.   

Abstract

The effects of the metabotropic glutamate receptor (mGluR) agonist (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid [(1S,3R)-ACPD] and a series of phenylglycine-derived putative mGluR antagonists were examined on electrophysiological responses mediated by glutamate and GABA receptors in the nucleus of the tractus solitarius (NTS) in transverse brainstem slices of the rat. Monosynaptic excitatory currents (EPSC's) evoked by electrical stimulation in the region of the tractus solitarius (TS) were reduced in the presence of (1S,3R)-ACPD in > 90% of neurons recorded in the dorsomedial subdivision of the NTS adjacent to the area postrema (AP). Monosynaptic evoked inhibitory currents (IPSC's) were similarly inhibited by (1S,3R)-ACPD. The inward current evoked by pressure application of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (IAMPA) was potentiated in the presence of (1S,3R)-ACPD, whereas the outward current evoked by the gamma-amino-butyric acid-A (GABA-A) receptor agonist muscimol (IMUSC) was inhibited. (1S,3R)-APCD also produced a postsynaptic inward current (IK(ACPD)) associated with a decrease in membrane conductance in approximately 50% of cells. The novel mGluR antagonists (S)-4-carboxy-3-hydroxy-phenylglycine (4C3H-PG), (R,S)-4-carboxy-phenylglycine (4C-PG) and (R,S)-alpha-methyl-4-carboxy-phenylglycine (alpha M4C-PG) reversibly antagonized the effects of (1S,3R)-ACPD on EPSC's IPSC's, IAMPA and IMUSC. The first two compounds also displayed weak agonist activity. However, none of the antagonists significantly inhibited IK(ACPD) at concentrations which blocked (1S,3R)-ACPD effects on synaptic transmission. These results suggest that pharmacologically distinct mGluR's may be present in the NTS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7512236     DOI: 10.1016/0028-3908(93)90039-6

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  7 in total

1.  Disinhibition of the cardiac limb of the arterial baroreflex in rat: a role for metabotropic glutamate receptors in the nucleus tractus solitarii.

Authors:  Annabel E Simms; Julian F R Paton; Anthony E Pickering
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

2.  Regulation of intrinsic and synaptic properties of neonatal rat trigeminal motoneurons by metabotropic glutamate receptors.

Authors:  C A Del Negro; S H Chandler
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

3.  Heterosynaptic crosstalk: GABA-glutamate metabotropic receptors interactively control glutamate release in solitary tract nucleus.

Authors:  L G Fernandes; Y-H Jin; M C Andresen
Journal:  Neuroscience       Date:  2010-12-01       Impact factor: 3.590

4.  Type I and II metabotropic glutamate receptor agonists and antagonists evoke cardiovascular effects after intrathecal administration in conscious rats.

Authors:  X C Li; P M Beart; J A Monn; N M Jones; R E Widdop
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

5.  Pharmacology of postsynaptic metabotropic glutamate receptors in rat hippocampal CA1 pyramidal neurones.

Authors:  C H Davies; V R Clarke; D E Jane; G L Collingridge
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

6.  Actions of two new antagonists showing selectivity for different sub-types of metabotropic glutamate receptor in the neonatal rat spinal cord.

Authors:  D E Jane; P L Jones; P C Pook; H W Tse; J C Watkins
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

7.  Pre- and postsynaptic glutamate receptors at a giant excitatory synapse in rat auditory brainstem slices.

Authors:  M Barnes-Davies; I D Forsythe
Journal:  J Physiol       Date:  1995-10-15       Impact factor: 5.182

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.